COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer
Clinical trial NCT07328087 · RECRUITING
Trial details
- NCT number
- NCT07328087
- Sponsor
- Biogenea Pharmaceuticals Ltd.
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2030-12-02
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.